series-c-plus
Stage
2
Investors
About
MapLight Therapeutics is a clinical-stage biotechnology company developing novel therapeutics for neuropsychiatric and neurological disorders such as schizophrenia, Alzheimer's, and Parkinson's disease.
Explore MapLight Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.